Two distinct species of the thermostable inhibitor of the cAMP-dependent protein kinase, PKI␣ and PKI, exist that are the products of separate genes. The PKI form, as first isolated from rat testis, is a 70-amino acid protein, but the genomic sequence suggested that an alternate form might exist, arising as a consequence of alternate translational initiation. This species, now termed PKI-78, has been synthesized by bacterial expression, demonstrated to be equipotent with PKI-70, and also now demonstrated to occur in vivo. By Western blot analyses, six additional species of PKI are also evident in tissues. Two of these represent the phospho forms of PKI-78 and PKI-70. The other four represent phospho and dephospho forms of two higher molecular mass PKI species. These latter forms are currently termed PKI-X and PKI-Y, awaiting the full elucidation of their molecular identity. In adult rat testis and cerebellum, PKI-70, PKI-X, and PKI-Y constitute 39, 23, and 32% and 15, 29, and 54% of the total tissue levels, respectively. In adult rat testis, 35-42% of each of these three species is present as a monophospho form, whereas no phosphorylation of them is evident in cerebellum. PKI-78 is present at much lower levels in both rat testis and cerebellum (ϳ6 and 2% of the total, respectively) and almost entirely as a monophospho species. PKI-78, like PKI-70, is a high affinity and specific inhibitor of the cAMP-dependent protein kinase. PKI-Y and PKI-X, in contrast, also significantly inhibit the cGMP-dependent protein kinase.The cAMP-dependent protein kinase (PKA) 1 plays a central role in the signal transduction of many hormones. The thermostable protein kinase inhibitor (PKI) is a highly specific competitive inhibitor of this enzyme that binds with high affinity to the protein substrate-binding site of the kinase (1). Its role as a regulator of PKA remains to be fully identified and appears to include not only the reduction of protein kinase activity, but also the trafficking of the protein kinase catalytic subunit between subcellular sites (2-4). Two genetically distinct forms of PKI (␣ and ) have been shown to be present in many tissues (5-9). Both forms act as specific pseudosubstrate inhibitors of PKA, have similar K i values in the subnanomolar range, and are likely both involved in intracellular trafficking (4). PKI␣ and PKI share ϳ40% identity at the amino acid level (5), share very closely the same recognition determinants for the catalytic subunit of PKA (5, 10) and for nuclear export (9), but are notably distinct in the C-terminal half of the molecule. PKI␣ and PKI each have a distinct tissue distribution (6).The PKI form was first identified in rat testis (5) in a follow-up of observations made earlier by Means and co-workers (11, 12). The PKI form purified was one of what appeared to be multiple forms of the protein present in testis, as was apparent from the DEAE chromatographic profile of the partially purified protein. The form purified was shown by protein sequencing and amino acid...